Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • biocon

    Tag: biocon

    You Searched For "biocon"
    Biocon gets EIR from USFDA for Bengaluru biologics unit

    Biocon gets EIR from USFDA for Bengaluru biologics unit

    Medical Dialogues Bureau6 Nov 2019 9:19 AM IST
    New Delhi: Biopharmaceutical firm Biocon on Tuesday said it has received an establishment inspection report (EIR) from the US health regulator for its...
    Biocon, Mylan launch insulin biosimilar Semglee in Australia

    Biocon, Mylan launch insulin biosimilar Semglee in Australia

    Medical Dialogues Bureau3 Oct 2019 3:51 PM IST
    New Delhi: Biotechnology major Biocon and pharmaceutical company Mylan N V on Thursday announced the launch of their insulin biosimilar Semglee,...
    Biocon gets USFDA Form 483 with 8 observations for 2 new facilities in Bengaluru

    Biocon gets USFDA Form 483 with 8 observations for 2 new facilities in Bengaluru

    Medical Dialogues Bureau23 Sept 2019 10:15 AM IST
    "At the conclusion of the inspection, we received a Form 483 with four observations for the new Drug Substance facility, three observations for the...
    Biocon Chief Kiran Shaw, FM Nirmala Sitharaman in tiff over E-Cigarette ban

    Biocon Chief Kiran Shaw, FM Nirmala Sitharaman in tiff over E-Cigarette ban

    Farhat Nasim20 Sept 2019 5:01 PM IST
    New Delhi: Biocon Chief Kiran Mazumdar Shaw recently got into a spat with the Finance Minister Nirmala Sitharaman on Thursday. The minister defended...
    Biocon inks license, supply pact with CMS for 3 generic formulations

    Biocon inks license, supply pact with CMS for 3 generic formulations

    Medical Dialogues Bureau13 Sept 2019 2:45 PM IST
    Under the terms of the agreement, Biocon will be responsible for the development, manufacturing and supply of the products and China Medical System...
    We need measures to save jobs in Automotive Sector: Biocon MD Kiran Mazumdar Shaw

    We need measures to save jobs in Automotive Sector: Biocon MD Kiran Mazumdar Shaw

    Medical Dialogues Bureau11 Sept 2019 9:30 AM IST
    "Passenger Vehicle Sales See Worst Ever Monthly Drop Since 1997-98 - we need measures that r not abt saving auto sector but abt saving 50% of...
    Syngene, Narayana Health, AIF launch CHAMPS- unique initiative to prevent, manage early onset of NCDs

    Syngene, Narayana Health, AIF launch CHAMPS- unique initiative to prevent, manage early onset of NCDs

    Medical Dialogues Bureau15 Aug 2019 9:30 AM IST
    The combined synergies of Narayana Health as a knowledge partner, Syngene and Biocon Foundation as funding partners and Agastya International as the...
    Biocon appoints Mayank Verma as Company Secretary, Compliance Officer

    Biocon appoints Mayank Verma as Company Secretary, Compliance Officer

    Farhat Nasim27 July 2019 9:00 AM IST
    Prior to joining the Biocon Group, Mayank Verma has worked with ING Vysya Bank Limited from 2007 to 2012.New Delhi: Biotechnology major, Biocon has...
    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    NPPA notices worth Rs 101 crore sent to Biocon, Lupin, Dr Reddys, others for skipping regulatory nod-Minister 

    Medical Dialogues Bureau24 July 2019 12:16 PM IST
    NPPA has so far issued demand notices for an amount of Rs 101 crore against defaulting companies. Out of this, an amount of Rs 5.56 crore has been...
    Biocon Chief Kiran Mazumdar Shaw, husband donate over Rs 51 crore to University of Glasgow

    Biocon Chief Kiran Mazumdar Shaw, husband donate over Rs 51 crore to University of Glasgow

    Medical Dialogues Bureau13 July 2019 12:55 PM IST
    A further donation of USD 2.5 million will go towards creating a new Professorial Chair to be named the Mazumdar-Shaw Chair of Precision Oncology....
    Biocon, Mylan gets Canadian nod for biosimilar of cancer drug Herceptin

    Biocon, Mylan gets Canadian nod for biosimilar of cancer drug Herceptin

    Farhat Nasim23 May 2019 11:59 AM IST
    Ogivri is the first trastuzumab biosimilar approved in Canada and the second biosimilar from Biocon and Mylan's joint portfolio approved in the...
    Biocon commercial rights on biosimilar adalimumab extends to global markets

    Biocon commercial rights on biosimilar adalimumab extends to global markets

    Farhat Nasim8 May 2019 9:45 AM IST
    Biocon, under the terms of its global partnership with Mylan for monoclonal antibodies, retains its economic interest in this expanded in-licensing...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok